Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Clinical Psychopharmacology|April 23, 2004
A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depressionMark Zimmerman, Iwona Chelminski, Michael PosternakThe Journal of Nervous and Mental Disease|September 7, 2004
A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depressionMark Zimmerman, Iwona Chelminski, Michael PosternakJournal of Affective Disorders|April 20, 2004
An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trialsMark Zimmerman, Iwona Chelminski, Michael PosternakDialogues in Clinical Neuroscience|January 28, 2009
Toward achieving optimal response: understanding and managing antidepressant side effectsKaren Kelly, Michael Posternak, Jonathan E AlpertThe International Journal of Neuropsychopharmacology|March 14, 2007
A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant responseMichael Posternak, Scott Novak, Robert Stern, et al.Journal of Affective Disorders|October 9, 2007
Predicting recovery from episodes of major depressionDavid A Solomon, Andrew C Leon, William Coryell, et al.The American Journal of Psychiatry|July 2, 2004
Which factors influence psychiatrists' selection of antidepressants?Mark Zimmerman, Michael Posternak, Michael Friedman, et al.Pageof 1